Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9307553 | 0.69 | ALDH1A1 (0.36) | PTGS1ALDH1A1MAPTTP53TSHR | |
| SCHEMBL8712173 | 0.65 | — | — | |
| SCHEMBL2128606 | 0.63 | — | — | |
| SCHEMBL3315318 | 0.61 | — | — | |
| SCHEMBL3067690 | 0.60 | ALDH1A1 (0.40) | PTGS1ALDH1A1MAPTTP53TSHR | |
| SCHEMBL8715609 | 0.60 | — | — | |
| Ammonia Solution, Strong SCHEMBL9345860 | 0.60 | — | — | |
| SCHEMBL8715819 | 0.60 | — | — | |
| SCHEMBL12238381 | 0.60 | — | — | |
| SCHEMBL1425816 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008064040-A2 | METHODS AND COMPOSITIONS USING CHELATOR-ANTIBODY CONJUGATES | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2008-05-29 | — | — | WO | claimed |
| US-20170281806-A1 | CHELATOR-TARGETING LIGAND CONJUGATES FOR CARDIOVASCULAR IMAGING | CELL>POINT LLC (US) | 2017-10-05 | — | — | US | disclosed |
| US-20110085969-A1 | CHELATOR-TARGETING LIGAND CONJUGATES FOR CARDIOVASCULAR IMAGING | CELL>POINT, LLC | 2011-04-14 | — | — | US | disclosed |
| WO-2011044377-A2 | CHELATOR-TARGETING LIGAND CONJUGATES FOR CARDIOVASCULAR IMAGING | CELL POINT, LLC (US) | 2011-04-14 | — | — | WO | disclosed |
| US-20100104511-A1 | METHODS AND COMPOSITIONS USING CHELATOR-ANTIBODY CONJUGATES | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-04-29 | — | — | US | disclosed |
| WO-2008064040-A2 | METHODS AND COMPOSITIONS USING CHELATOR-ANTIBODY CONJUGATES | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2008-05-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170281806-A1 | CHELATOR-TARGETING LIGAND CONJUGATES FOR CARDIOVASCULAR IMAGING | SLC2A8, SLC2A1, SLC2A2 | PTGS1 4152/4885ALDH1A1 3309/4885MAPT 4039/4885 |
| US-20110085969-A1 | CHELATOR-TARGETING LIGAND CONJUGATES FOR CARDIOVASCULAR IMAGING | SLC2A8, SLC2A1, SLC2A2 | PTGS1 4152/4885ALDH1A1 3309/4885MAPT 4039/4885 |
| US-20100104511-A1 | METHODS AND COMPOSITIONS USING CHELATOR-ANTIBODY CONJUGATES | ERBB2, EGFR, ERBB3 | PTGS1 4822/4885ALDH1A1 4692/4885MAPT 2140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.